Quantification of CCI-103F labeling heterogeneity in canine solid tumors

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 3, 1997, Pages 655-662

  Cline, J Mark ^a   Rosner, Gary L ^b   Raleigh, James A ^c   Thrall, Donald E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Canine tumors; CCI 103F; Hypoxia; Hypoxia markers; Nitroimidazole markers; Sampling error

Indexed keywords

1 (1,1,1,3,3,3 HEXAFLUORO 2 PROPOXY) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; NITROIMIDAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL LABELING; DOG; HYPOXIC CELL; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; TUMOR VOLUME;

ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; CELL HYPOXIA; DOG DISEASES; DOGS; NEOPLASMS; NITROIMIDAZOLES; OXYGEN; REPRODUCIBILITY OF RESULTS;

EID: 0030907770     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00559-7     Document Type: Article

References (24)

1. Arteel, G. E.; Thurman, R. G.; Yates, J. M.; Raleigh, J. A. Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion in rat livers. Br. J. Cancer 72:889-895; 1995.
2. Barranco, S. C.; Perry, R. R.; Durm M. E.; Werner, A. L.; Gregorcyk, S. G.; Bolton, W. E.; Kolm, P.; Townsend, C. M., Jr. Intratumor variability in prognostic indicators may be the cause of conflicting estimates of patient survival and response to therapy. Cancer Res 54:5351-5356; 1994.
3. Chapman, J. D.; Baer, K.; Lee, J. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res 43:1523-1528; 1983.
4. Cline, J. M.; Rosner, G. L.; Azuma, C.; Raleigh; J. A.; Thrall, D. E. Intratumor and intrabiopsy labeling variation of a 2-nitroimidazole hypoxia marker in canine tumors. Ninth International conference on chemical modifiers of cancer treatment. Oxford, England; 1995:283-284.
5. Cline, J. M.; Thrall, D. E.; Page. R. L.; Franko, A. J.; Raleigh, J. A. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours. Br. J. Cancer 62:925-931; 1991.
6. Cline, J. M.; Thrall, D. E.; Rosner, G. L.; Raleigh, J. A. Distribution of the hypoxia marker CCI-103F in canine tumors. Int. J. Radiat. Oncol. Biol. Phys. 28:921-933; 1994.
7. de Jong, J. S.; van Diest, P. J.; Baak, J. P. A. Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab. Invest. 73:922-926; 1995.
8. 2 saturations. Radiat. Res. 141:49-56; 1995.
9. Ferno, M.; Baldetorp, B.; Ewers, S.; Idvall, I.; Olsson, H.; Sigurdsson, H.; Killander, D. One or more samplings for flow cytometric DNA analyses in breast cancer-prognostic implications? Cytometry 13:241-249; 1992.
10. Gatenby, R. A.; Kessler, H. B.; Rosenblum, J. S.; Coia, L. R.; Moldofsky, P. J.; Hartz, W. H.; Broder, G. J. Oxygen distribution in squamous cell carcinoma metastases and its relationship in outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14:831-838; 1988.
11. Mueller-Klieser, W.; Schlenger, H.; Walenta, S.; Gross, M.; Karbach, U.; Hoeckel, U.; Vaupel, P. Pathophysiological approaches to identifying tumor hypoxia in patients. Radiother. Oncol. Suppl. 20:21-28; 1991.
12. Petersen, S. E.; Bichel, P.; Lorentzen, M. Flow-cytometric demonstration of tumour-cell subpopulations with different DNA content in human colorectal carcinoma. Eur. J. Cancer 15:383-386: 1979.
13. Raleigh, J. A.; Chou, S.-C.; Fish, B.; Moulder, J. E. Relationship between intensity of hypoxia marker binding and radiobiological hypoxic fraction in murine tumors. 42nd Annual Meeting of the Radiation Research Society, Nashville, TN, 1994:227.
14. Raleigh, J. A.; Dewhirst, M. W.; Thrall, D. E. Measuring tumor hypoxia. Semin. Radiat. Oncol. 6:37-45; 1996.
15. Raleigh, J. A.; Franko, A. J.; Breiber, E. O.; Lunt, J. A.; Allen, P. S. Covalent binding of fluorinated 2-nitroimidazole to EMT-6 tumours in BALB/C mice. Detection by F-19 nuclear magnetic resonance at 2.35T. Int. J. Radiat. Oncol. Biol. Phys. 12:1249-1251; 1986.
16. Raleigh, J. A.; Miller, G. G.; Franko, A. J.; Koch, C. J.; Fuciarelli, A. F.; Kelly, D. A. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br. J. Cancer 56:395-400; 1987.
17. SAS Institute. SAS Technical Report P-229, SAS/STAT Software: Changes and enhancements, release 6.07 (Chapter 16: The MIXED Procedure). Cary, NC: SAS Institute Inc.; 1992.
18. Snedecor, G. W.; Cochran, W. G. Statistical methods, 6th ed. Ames, IA: The Iowa State University Press; 1967.
19. Thomlinson, R. H.; Gray, L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9:539-549; 1955.
20. Thrall, D. E.; McEntee, M. C.; Cline, J. M.; Raleigh, J. A. ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation. Int. J. Radiat, Oncol. Biol. Phys. 28:649-659; 1994.
21. 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 12:1263-1267; 1986.
22. 2 tension measurements. Cancer Res 51:3316-3322; 1991.
23. Wendung, P.; Manz, R.; Thews, G.; Vaupel, P. Heterogeneous oxygenation of rectal carcinomas in humans: A critical parameter for preoperative irradiation? Adv. Exp. Med. Biol. 180:293: 1985.
24. Wordinger, R. J.; Miller, G. W.; Nicodemus, D. S. Manual of immunoperoxidase techniques, 2nd edition. Chicago, IL: American Society of Clinical Pathologists Press.; 1987.